Humana (HUM)
(Delayed Data from NYSE)
$387.38 USD
-1.51 (-0.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $387.35 -0.03 (-0.01%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$387.38 USD
-1.51 (-0.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $387.35 -0.03 (-0.01%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Zacks News
HMOs Burn Hot This Summer
by John Blank
This 13-company industry is currently ranked #16 out of 265 industries of Zacks ranks (top 6%). You can't do better than that when there are this many companies inside a given industry.
Health Insurers Walk Tightrope with ACA Challenges
by Zacks Equity Research
Players in the U.S. health insurance industry are expected to suffer from narrowed operating margins for the next few years.
Health Insurers Shine in Obamacare Era
by Zacks Equity Research
Carriers in the health insurance sector are in a race to win Medicare Advantage market share and the fastest way of achieving the target by acquiring a company in the same business.
Health Insurance Stock Outlook - June 2015
by Abhijit Ghosh
Although previously feared by the insurers, the changes and challenges put forth by the health care reform act haven't really caused damage to them.
Health Insurance Stock Outlook - June 2015
by Zacks Equity Research
Although previously feared by the insurers, the changes and challenges put forth by the health care reform act haven't really caused damage to them.
Health Insurers Continue to Face ACA Challenges
by Zacks Equity Research
The biggest uncertainty now is that subsidies made available by the Affordable Care Act (ACA) have been challenged in the Supreme Court.
Health Insurers Find ObamaCare Headwinds Easing
by Zacks Equity Research
Insurers are eying growth and expansion opportunities accompanying the critical challenges of modernizing the health care system.
Health Insurance Stock Outlook - Feb. 2015
by Zacks Equity Research
Fears of adverse selection, premium increases, and stratospheric managed care medical loss ratios abated and the players started refocusing on long-term growth opportunities.
Health Insurance Stock Outlook - Feb. 2015
by Zacks Equity Research
Fears of adverse selection, premium increases, and stratospheric managed care medical loss ratios abated and the players started refocusing on long-term growth opportunities.
Stocks with Upgraded Broker Ratings
by Kevin Matras
Kevin Matras explains why looking for stocks with upgraded broker ratings can upgrade your portfolio to a whole new level. Highlighted stocks include HLSS, HUM, MDVN, NTAP and SNDK.